Warning: This security is no longer trading.
Exact Sciences completes $2.8B acquisition of Genomic Health
Genomic Health, Inc. (GHDX): Price and Financial Metrics
GHDX Price/Volume Stats
| Current price | $63.44 | 52-week high | $90.18 |
| Prev. close | $63.88 | 52-week low | $50.77 |
| Day low | $62.74 | Volume | 12,537,000 |
| Day high | $64.57 | Avg. volume | 586,356 |
| 50-day MA | $69.75 | Dividend yield | N/A |
| 200-day MA | $67.25 | Market Cap | 2.38B |
GHDX Stock Price Chart Interactive Chart >
Genomic Health, Inc. (GHDX) Company Bio
Genomic Health provides actionable genomic information to personalize cancer treatment decisions in the United States and internationally. It develops and commercializes genomic-based clinical laboratory services that analyze the underlying biology of cancer, allowing physicians and patients to make individualized treatment decisions. The company was founded in 2000 and is based in Redwood City, California.
GHDX Price Returns
| 1-mo | N/A |
| 3-mo | N/A |
| 6-mo | N/A |
| 1-year | N/A |
| 3-year | N/A |
| 5-year | 2.44% |
| YTD | N/A |
| 2023 | N/A |
| 2022 | N/A |
| 2021 | N/A |
| 2020 | N/A |
| 2019 | 0.00% |
Loading social stream, please wait...